PRECIGEN, INC. Deferred Income Tax Expense (Benefit)
PRECIGEN, INC. (PGEN) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-25
- PRECIGEN, INC. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $0.00.
- PRECIGEN, INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. deferred income tax expense (benefit) for the quarter ending 2025-06-30 was $0.00.
- PRECIGEN, INC. deferred income tax expense (benefit) for the quarter ending 2025-03-31 was $0.00.
- PRECIGEN, INC. deferred income tax expense (benefit) for fiscal 2025 was $0.00.
- PRECIGEN, INC. deferred income tax expense (benefit) for fiscal 2024 was -$1.79M.
- PRECIGEN, INC. deferred income tax expense (benefit) for fiscal 2023 was -$479.00K.
- PRECIGEN, INC. deferred income tax expense (benefit) for fiscal 2022 was -$150.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | -$89.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | -$89.00K derived: sum of 3 quarters · filed 2026-03-25 | -$77.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | -$89.00K derived: sum of 2 quarters · filed 2026-03-25 | -$77.00K derived: sum of 3 quarters · filed 2026-03-25 | -$1.77M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | -$89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$77.00K derived: sum of 2 quarters · filed 2026-03-25 | -$1.77M derived: sum of 3 quarters · filed 2026-03-25 | -$1.79M 10-K · filed 2026-03-25 |
| 2024-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.68M derived: sum of 2 quarters · filed 2025-11-13 | -$1.71M 10-Q · filed 2025-11-13 | -$2.06M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | -$1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.72M 10-Q · filed 2025-08-12 | -$2.07M derived: sum of 3 quarters · filed 2026-03-25 | -$2.08M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | -$29.00K 10-Q · filed 2025-05-14 | -$382.00K derived: sum of 2 quarters · filed 2026-03-25 | -$395.00K derived: sum of 3 quarters · filed 2026-03-25 | -$453.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | -$353.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$366.00K derived: sum of 2 quarters · filed 2026-03-25 | -$424.00K derived: sum of 3 quarters · filed 2026-03-25 | -$479.00K 10-K · filed 2026-03-25 |
| 2023-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$71.00K derived: sum of 2 quarters · filed 2024-11-14 | -$126.00K 10-Q · filed 2024-11-14 | -$114.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-06-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$113.00K 10-Q · filed 2024-08-14 | -$101.00K derived: sum of 3 quarters · filed 2025-03-19 | -$151.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-03-31 | -$55.00K 10-Q · filed 2024-05-14 | -$43.00K derived: sum of 2 quarters · filed 2025-03-19 | -$93.00K derived: sum of 3 quarters · filed 2025-03-19 | -$147.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2022-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$38.00K derived: sum of 2 quarters · filed 2025-03-19 | -$92.00K derived: sum of 3 quarters · filed 2025-03-19 | -$150.00K 10-K · filed 2025-03-19 |
| 2022-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$104.00K derived: sum of 2 quarters · filed 2023-11-09 | -$162.00K 10-Q · filed 2023-11-09 | -$149.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$112.00K 10-Q · filed 2023-08-09 | -$99.00K derived: sum of 3 quarters · filed 2024-03-19 | -$160.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | -$58.00K 10-Q · filed 2023-05-10 | -$45.00K derived: sum of 2 quarters · filed 2024-03-19 | -$106.00K derived: sum of 3 quarters · filed 2024-03-19 | -$169.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$48.00K derived: sum of 2 quarters · filed 2024-03-19 | -$111.00K derived: sum of 3 quarters · filed 2024-03-19 | -$167.00K 10-K · filed 2024-03-19 |
| 2021-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$124.00K derived: sum of 2 quarters · filed 2022-11-09 | -$180.00K 10-Q · filed 2022-11-09 | -$132.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$119.00K 10-Q · filed 2022-08-08 | -$71.00K derived: sum of 3 quarters · filed 2023-03-06 | -$139.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | -$56.00K 10-Q · filed 2022-05-09 | -$8.00K derived: sum of 2 quarters · filed 2023-03-06 | -$76.00K derived: sum of 3 quarters · filed 2023-03-06 | -$212.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$20.00K derived: sum of 2 quarters · filed 2023-03-06 | -$156.00K derived: sum of 3 quarters · filed 2023-03-06 | -$156.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | -$68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$204.00K derived: sum of 2 quarters · filed 2021-11-08 | -$204.00K 10-Q · filed 2021-11-08 | -$2.43M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$136.00K 10-Q · filed 2021-08-09 | -$2.36M derived: sum of 3 quarters · filed 2022-03-01 | -$2.83M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | -$2.23M derived: sum of 2 quarters · filed 2022-03-01 | -$2.69M derived: sum of 3 quarters · filed 2022-03-01 | -$3.17M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.69M derived: sum of 2 quarters · filed 2022-03-01 | -$3.17M derived: sum of 3 quarters · filed 2022-03-01 | -$3.67M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$467.00K 10-Q · filed 2019-11-12 | -$940.00K derived: sum of 2 quarters · filed 2019-11-12 | -$1.45M 10-Q · filed 2020-11-09 | -$3.39M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$473.00K 10-Q · filed 2019-08-09 | -$981.00K 10-Q · filed 2020-08-10 | -$2.92M derived: sum of 3 quarters · filed 2021-03-01 | -$17.17M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$508.00K 10-Q · filed 2020-05-11 | -$2.45M derived: sum of 2 quarters · filed 2021-03-01 | -$16.70M derived: sum of 3 quarters · filed 2021-03-01 | -$17.71M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$16.19M derived: sum of 2 quarters · filed 2021-03-01 | -$17.20M derived: sum of 3 quarters · filed 2021-03-01 | -$21.28M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$14.25M 10-Q · filed 2019-11-12 | -$15.26M derived: sum of 2 quarters · filed 2019-11-12 | -$19.34M 10-Q · filed 2019-11-12 | -$19.57M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$1.01M 10-Q · filed 2019-08-09 | -$5.09M 10-Q · filed 2019-08-09 | -$5.32M derived: sum of 3 quarters · filed 2020-03-02 | -$6.10M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$4.07M 10-Q · filed 2019-05-09 | -$4.31M derived: sum of 2 quarters · filed 2020-03-02 | -$5.08M derived: sum of 3 quarters · filed 2020-03-02 | -$5.96M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$1.01M derived: sum of 2 quarters · filed 2020-03-02 | -$1.89M derived: sum of 3 quarters · filed 2020-03-02 | -$2.53M 10-K · filed 2020-03-02 |
| 2017-09-30 | -$775.00K 10-Q · filed 2018-11-08 | -$1.66M derived: sum of 2 quarters · filed 2018-11-08 | -$2.29M 10-Q · filed 2018-11-08 | -$2.79M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$881.00K 10-Q · filed 2018-08-13 | -$1.52M 10-Q · filed 2018-08-13 | -$2.02M derived: sum of 3 quarters · filed 2019-03-01 | -$2.33M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$638.00K 10-Q/A · filed 2018-08-13 | -$1.14M derived: sum of 2 quarters · filed 2019-03-01 | -$1.45M derived: sum of 3 quarters · filed 2019-03-01 | -$1.92M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$808.00K derived: sum of 2 quarters · filed 2019-03-01 | -$1.28M derived: sum of 3 quarters · filed 2019-03-01 | -$3.47M 10-K · filed 2019-03-01 |
| 2016-09-30 | -$308.00K 10-Q · filed 2017-11-09 | -$779.00K derived: sum of 2 quarters · filed 2017-11-09 | -$2.97M 10-Q · filed 2017-11-09 | -$2.22M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | -$471.00K 10-Q · filed 2017-08-09 | -$2.66M 10-Q · filed 2017-08-09 | -$1.92M derived: sum of 3 quarters · filed 2018-03-01 | -$2.49M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$2.19M 10-Q · filed 2017-05-10 | -$1.45M derived: sum of 2 quarters · filed 2018-03-01 | -$2.02M derived: sum of 3 quarters · filed 2018-03-01 | -$1.87M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $743.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $165.00K derived: sum of 2 quarters · filed 2018-03-01 | $322.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.12M 10-K · filed 2018-03-01 |
| 2015-09-30 | -$578.00K 10-Q · filed 2016-11-09 | -$421.00K derived: sum of 2 quarters · filed 2016-11-09 | $374.00K 10-Q · filed 2016-11-09 | $374.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $157.00K 10-Q · filed 2016-08-09 | $952.00K 10-Q · filed 2016-08-09 | $952.00K derived: sum of 3 quarters · filed 2017-03-01 | $952.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $795.00K 10-Q · filed 2016-05-10 | $795.00K derived: sum of 2 quarters · filed 2017-03-01 | $795.00K derived: sum of 3 quarters · filed 2017-03-01 | $795.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 derived: sum of 3 quarters · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |